Pharma Pulse 10/14/24: Trading Quality for Convenience? Specialists Not High on Improving Medicinal Cannabis Access
The latest news for pharma industry insiders.
Trading Quality for Convenience? The New Tech Balancing Act
Announcements such as Apple’s come with pros and cons for industry.
Pain Specialists Not High on Improving Access to Medicinal Cannabis
Research reveals differences between physicians and adults suffering from chronic pain in levels of support for cannabis access, signifying implications for policymaking and healthcare practices regarding cannabis use. Results from the survey were published this past September 2024 in JAMA Network Open. The survey captured the attitudes of two key groups about cannabis policies and expanding access to cannabis for chronic pain management in states with active medical cannabis programs.
MicroRNA Pioneers Win Nobel Prize in Medicine
Americans Victor Ambros and Gary Ruvkun discovered tiny molecules that affect gene regulation.
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), is donating another $500,000 toward relief and healing efforts in the wake of the second Hurricane to hit Florida in two weeks. After consecutive disasters and concern for everyone in the path of these storms, the Humana Foundation will bring its total support to $1.5 million. Like the steps Humana took to aid members, communities and employees across the path of Hurricane Helene, it will do the same with Milton, by providing access to medical and emergency prescription information, and continuing access to a crisis hotline with free counseling.
I'll be heading down to DC for IntegriChain's Access Insights Conference! Looking forward to catching up with many familiar faces, including William Roth, who happens to pen Pharmaceutical Commerce Magazine's "Commercialization Corner" column. Our pub is also one of the event sponsors, and I'll be there covering sessions and conducting video interviews with the wonderful KOLs that will be sharing the latest trends, strategies, insights, and tactics for data-driven access and commercialization.
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
